Prevalence of scabies and associated factors among children aged 5-14 years in Meta Robi District, Ethiopia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 31 05 2022
accepted: 05 11 2022
entrez: 3 1 2023
pubmed: 4 1 2023
medline: 6 1 2023
Statut: epublish

Résumé

Scabies is a public health problem that affects children and elders predominantly. Its burden is higher in resource-poor settings, and scabies has a significant impact on the long-term health of children. In Ethiopia, there is limited information about scabies in children. Therefore, the purpose of this study was to determine the prevalence of scabies and its associated factors among children aged 5-14 years in Meta Robi District, Ethiopia. A community-based cross-sectional study design using a multistage sampling technique was used to collect data from 457 participants by systematic random sampling. Scabies was diagnosed based on the clinical criteria set by the International Alliance for the Control of Scabies (IACS, 2020). The prevalence of scabies among children aged 5-14 years old was 19.26% (95%CI: 17.20-22.52). In addition, over half (54.6%) of identified cases of scabies were of moderate severity. Factors like families' low income (aOR = 2.72; 95%CI: 1.32-5.59), being a male child (aOR = 1.96, 95%CI: 1.61-4.01), using only water for hand washing (aOR = 2.01, 95%CI: 1.84-4.79), having a contact history of scabies/skin lesions (aOR = 4.15, 95%CI: 2.02-13.67), and sharing sleeping beds (aOR = 6.33, 95%CI: 2.09-19.13) were significantly associated with scabies. The study highlights a high prevalence of scabies among children aged 5-14 years in the district. Provision of adequate health education for the community and children about the scabies and delivering mass drug administration to the district is suggested.

Sections du résumé

BACKGROUND
Scabies is a public health problem that affects children and elders predominantly. Its burden is higher in resource-poor settings, and scabies has a significant impact on the long-term health of children. In Ethiopia, there is limited information about scabies in children. Therefore, the purpose of this study was to determine the prevalence of scabies and its associated factors among children aged 5-14 years in Meta Robi District, Ethiopia.
METHODS
A community-based cross-sectional study design using a multistage sampling technique was used to collect data from 457 participants by systematic random sampling. Scabies was diagnosed based on the clinical criteria set by the International Alliance for the Control of Scabies (IACS, 2020).
FINDINGS
The prevalence of scabies among children aged 5-14 years old was 19.26% (95%CI: 17.20-22.52). In addition, over half (54.6%) of identified cases of scabies were of moderate severity. Factors like families' low income (aOR = 2.72; 95%CI: 1.32-5.59), being a male child (aOR = 1.96, 95%CI: 1.61-4.01), using only water for hand washing (aOR = 2.01, 95%CI: 1.84-4.79), having a contact history of scabies/skin lesions (aOR = 4.15, 95%CI: 2.02-13.67), and sharing sleeping beds (aOR = 6.33, 95%CI: 2.09-19.13) were significantly associated with scabies.
CONCLUSION
The study highlights a high prevalence of scabies among children aged 5-14 years in the district. Provision of adequate health education for the community and children about the scabies and delivering mass drug administration to the district is suggested.

Identifiants

pubmed: 36595503
doi: 10.1371/journal.pone.0277912
pii: PONE-D-22-15754
pmc: PMC9810185
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0277912

Informations de copyright

Copyright: © 2023 Ararsa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Trop Med Int Health. 2007 Apr;12(4):493-502
pubmed: 17445140
Parasit Vectors. 2016 Jul 19;9(1):400
pubmed: 27430556
PLoS Negl Trop Dis. 2019 Mar 8;13(3):e0007182
pubmed: 30849124
Emerg Microbes Infect. 2020 Dec;9(1):813-816
pubmed: 32284022
Parasite Immunol. 2014 Nov;36(11):585-93
pubmed: 25081184
PLoS Negl Trop Dis. 2017 Aug 3;11(8):e0005808
pubmed: 28771469
Environ Health Prev Med. 2019 Nov 30;24(1):67
pubmed: 31785612
Trop Med Infect Dis. 2018 Oct 29;3(4):
pubmed: 30380650
BMC Res Notes. 2019 May 29;12(1):305
pubmed: 31142358
PLoS Negl Trop Dis. 2013 Aug 08;7(8):e2167
pubmed: 23951369
Adv Parasitol. 2004;57:309-76
pubmed: 15504541
Dermatol Res Pract. 2018 Jun 26;2018:7276938
pubmed: 30046302
Res Rep Trop Med. 2019 Aug 27;10:119-127
pubmed: 31695552
Clin Microbiol Infect. 2012 Apr;18(4):313-23
pubmed: 22429456
BMC Pediatr. 2021 May 25;21(1):249
pubmed: 34034686
Lancet Infect Dis. 2015 Aug;15(8):960-7
pubmed: 26088526
An Bras Dermatol. 2014 Jul-Aug;89(4):609-15
pubmed: 25054748
Br J Dermatol. 2020 Nov;183(5):808-820
pubmed: 32034956
Clin Infect Dis. 2020 Apr 10;70(8):1591-1595
pubmed: 31131410
BMC Infect Dis. 2020 May 27;20(1):380
pubmed: 32460770
Lancet. 2019 Jul 6;394(10192):81-92
pubmed: 31178154
J Infect Dev Ctries. 2020 Jun 29;14(6.1):78S-85S
pubmed: 32614801
Pan Afr Med J. 2020 Nov 06;37:224
pubmed: 33520063
BMC Infect Dis. 2019 Sep 13;19(1):803
pubmed: 31519153
Curr Opin Infect Dis. 2012 Apr;25(2):145-53
pubmed: 22327467
PLoS Negl Trop Dis. 2018 May 17;12(5):e0006489
pubmed: 29771976
J Prev Med Hyg. 2013 Sep;54(3):153-8
pubmed: 24783893
Clin Cosmet Investig Dermatol. 2015 Feb 24;8:105-11
pubmed: 25759594
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
Lancet Infect Dis. 2017 Dec;17(12):1247-1254
pubmed: 28941561
J Infect Dev Ctries. 2020 Jun 29;14(6.1):28S-35S
pubmed: 32614793
PLoS Negl Trop Dis. 2020 Dec 22;14(12):e0008902
pubmed: 33351803
Sci Total Environ. 2021 Nov 1;793:148500
pubmed: 34174598
PLoS Negl Trop Dis. 2020 Dec 7;14(12):e0008943
pubmed: 33284821
N Engl J Med. 2006 Apr 20;354(16):1718-27
pubmed: 16625010

Auteurs

Gemechu Ararsa (G)

Gemechu Ararsa, West Shoa Zone Health Bureau, Oromia Region, Ambo, Ethiopia.

Emiru Merdassa (E)

Department of Public Health, Institute of Health Sciences, Wallaga University, Nekemte, Ethiopia.

Tesfaye Shibiru (T)

Department of Pediatrics and Child Health, School of Medicine, Wallaga University, Nekemte, Ethiopia.

Werku Etafa (W)

Department of Pediatrics and Child Health Nursing, Institute of Health Sciences, Wallaga University, Nekemte, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH